Supplementary Figure S7 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Combined AURKA and WEE inhibition reduces Ki-67, and elevates caspase-3, AURKA and TPX2 expression in xenograft tumors.
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7202347166
Cites:
Cited by:
Related to: